New filler aims to reshape aging chins without surgery
NCT ID NCT05986630
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a hyaluronic acid filler called TEOSYAL TPVM against another filler for improving chin shape and lower face aging. About 155 healthy adults with moderate to severe chin retrusion will receive injections, with an optional touch-up at 4 weeks. The main goal is to see if TEOSYAL is as good as the comparator at reducing chin retrusion 8 weeks after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TEOSYAL TPVM (hyaluronic acid dermal filler)
What this could lead to
If successful, this could offer a safe, effective option for non-surgical chin enhancement and lower face rejuvenation.
What could go wrong
This is a cosmetic study, not a treatment for a medical condition. Results may not apply to all skin types or ages, and fillers carry risks like swelling, bruising, or asymmetry.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Care- Geneva
Geneva, Switzerland